Groupama Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.27M Buy
53,429
+552
+1% +$44.5K 0.05% 115
2026
Q1
$4.58M Sell
52,877
-2,518
-5% -$241K 0.07% 106
2025
Q4
$5.32M Sell
55,395
-2,247
-4% -$218K 0.08% 109
2025
Q3
$5.49M Buy
57,642
+22,255
+63% +$2.05M 0.08% 104
2025
Q2
$3.04M Sell
35,387
-10,417
-23% -$883K 0.05% 143
2025
Q1
$4.01M Sell
45,804
-21,877
-32% -$1.96M 0.08% 119
2024
Q4
$5.39M Sell
67,681
-113,414
-63% -$9.82M 0.11% 108
2024
Q3
$6.57M Buy
181,095
+64,499
+55% +$5.43M 0.17% 92
2024
Q2
$4.63M Buy
116,596
+48,197
+70% +$3.95M 0.06% 135
2024
Q1
$8.08M Sell
68,399
-140,692
-67% -$12M 0.15% 114
2023
Q4
$8.64M Buy
+209,091
New +$15.9M 0.22% 86

Other funds holding MDT

Groupama Asset Management's MDT Position: Q2 2026 in Review

Groupama Asset Management increased its Medtronic (MDT) stake by 1% in Q2 2026, buying an estimated $44.5K and bringing the position to 53,429 shares worth $4.27M. The position accounts for 0.05% of the portfolio, ranked #115.

Groupama Asset Management first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.64M in Q4 2023. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Groupama Asset Management held 53,429 shares of Medtronic worth $4.27M as of Q2 2026.
  • Groupama Asset Management bought 552 Medtronic shares in Q2 2026, an estimated $44.5K.
  • Medtronic made up 0.05% of Groupama Asset Management's portfolio in Q2 2026, its #115 holding.
  • Groupama Asset Management first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's Medtronic position peaked at $8.64M in Q4 2023.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.